NCT06620107

Brief Summary

comparison between Noninvasive Intermittent Positive Pressure Ventilation (NIPPV) and Noninvasive High Frequency Oscillation Ventilation (NHFOV) post-extubation in preterm neonates as regards the efficacy and their possible complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
Last Updated

October 24, 2024

Status Verified

September 1, 2024

Enrollment Period

1 year

First QC Date

September 25, 2024

Last Update Submit

October 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • reintubation and the duration of respiratory support

    * The number of cases that required re-intubation and the time of failure of extubation in hours. * Duration of different types of respiratory support since birth till discharge from NICU.

    from the date of birth till the date of discharge from NICU or death (assessed up to 3 months)..

Secondary Outcomes (1)

  • complications

    from the date of birth till the date of discharge from NICU or death (assessed up to 3 months).

Study Arms (2)

Noninvasive high frequency oscillation ventilation

ACTIVE COMPARATOR

preterm neonates with GA of 32 to 36 weeks ready for extubation

Device: noninvasive high frequency oscillation ventilation

Noninvasive intermittent positive pressure ventilation

ACTIVE COMPARATOR

preterm neonates with GA of 32 to 36 weeks ready for extubation

Device: noninvasive positive pressure ventilation

Interventions

cases of group A extubated on NHFOV, and it will be provided by CNO, Medin device, Germany) via binasal prongs with the following parameters: * MAP of 6 cmH2O and will be titrated targeting a FiO2 ≤ 25-30%, maximum FiO2 will be 40% and target oxygen saturation will be 90-95%. * Frequency of 8 Hz and can be changed within the range of 8-12 Hz. * Amplitude of 7 cmH2O and can be titrated within the range of 7-10 cmH2O according to PaCO2.

Noninvasive high frequency oscillation ventilation

NIPPV will be provided by any type of neonatal ventilator available in the unit via binasal prongs starting with the following parameters: * Positive end expiratory pressure (PEEP) of 5 cmH2O and can be titrated to 8 cmH2O according to the oxygenation . * Peak inspiratory pressure (PIP) of 15 cmH2O and can be titrated to 25 cmH2O ,according to oxygenation , PaCO2 level and the chest expansion . * FiO2 ≤ 25-30% and can be increased to 40 % maximally targeting oxygen saturation of 90-95% . * Inspiratory time of 0.40-0.50 s . * Rate of 30 bpm and can be increased to maximum 50 bpm . * Synchronization will not be applied.

Noninvasive intermittent positive pressure ventilation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Preterm neonates with gestational age between 32 and 36 weeks and on mechanical ventilation ready to be extubated.
  • When the case is ready for extubation , will receive at least one loading dose of caffeine citrate (20 mg/kg/dose) and daily maintenance dose of 5 mg/kg/dose.
  • Criteria for extubation:
  • Blood gas analysis: PH \> 7.25 and PaCO2 ≤ 60 mmHg.
  • Airway pressure (Paw) of 7 to 8 cmH2O.
  • Required fraction of inspired oxygen (FiO2) ≤ 30%.
  • Sufficient spontaneous breathing by clinical evaluation.

You may not qualify if:

  • Full term neonates.
  • Preterm neonates who will not require intubation.
  • Preterm neonates with one of the following criteria:
  • birth weight \> 900 gms , major congenital anomalies, upper airway anomalies, neuromuscular diseases, surgical cases, intraventricular hemorrhage grade IV.
  • Cases that require reintubation after more than 72 hours of extubation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kafrelsheikh University

Kafrelsheikh, Egypt

Location

Related Publications (1)

  • Shi Y, Muniraman H, Biniwale M, Ramanathan R. A Review on Non-invasive Respiratory Support for Management of Respiratory Distress in Extremely Preterm Infants. Front Pediatr. 2020 May 28;8:270. doi: 10.3389/fped.2020.00270. eCollection 2020.

    PMID: 32548084BACKGROUND

Related Links

Study Officials

  • Heba SM El-Mahdy

    Tanta University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pediatric demonstrator at faculty of medicine- kafrelsheikh university

Study Record Dates

First Submitted

September 25, 2024

First Posted

October 1, 2024

Study Start

January 20, 2023

Primary Completion

January 20, 2024

Study Completion

January 20, 2024

Last Updated

October 24, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations